top of page
Search

Understanding Pyrroloquinoline Quinone (PQQ) and Its Potential Role in Parkinson's Disease




Pyrroloquinoline quinone, or PQQ, is a naturally occurring compound found in certain foods and available as a dietary supplement. Recent research suggests that PQQ may offer promising benefits for people with Parkinson's disease (PD), a progressive neurological disorder that affects movement and can cause tremors, stiffness, and balance problems.


How Does PQQ Work?


PQQ is gaining attention for its potential neuroprotective properties, especially in the context of Parkinson's disease.


Here’s how it may help Parkinsons:


1. Mitochondrial Health:

Mitochondria are the powerhouses of cells, responsible for producing energy. In Parkinson's disease, mitochondrial dysfunction is a significant problem, contributing to the death of dopamine-producing neurons. PQQ has been shown to protect mitochondria from damage in models of Parkinson's disease induced by a toxin called rotenone. By preventing mitochondrial dysfunction, PQQ may help slow down the progression of the disease.


2. Improving Motor Function:

One of the most challenging aspects of Parkinson's disease is the loss of motor control, leading to symptoms like tremors, stiffness, and difficulty with balance and coordination. In studies with mice that have Parkinson's-like symptoms, PQQ supplementation has been found to improve motor function. This suggests that PQQ might help people with Parkinson's maintain better control over their movements.


3. Protecting Dopaminergic Neurons:

The loss of dopaminergic neurons in the brain is a hallmark of Parkinson's disease. PQQ has shown promise in reducing the loss of these neurons in animal studies. By protecting these critical cells, PQQ could help preserve dopamine levels in the brain, potentially alleviating some symptoms of Parkinson's.


4. Reducing Alpha-Synuclein Aggregates:

Parkinson's disease is also characterized by the accumulation of a protein called alpha-synuclein in the brain. These protein aggregates, known as Lewy bodies, are toxic to neurons and contribute to the progression of the disease. In cellular models of Parkinson's, PQQ has been found to reduce the number and size of these alpha-synuclein aggregates, suggesting it might help prevent or slow the damage they cause.


The Future of PQQ in Parkinson's Treatment


While the research on PQQ is still in the early stages, particularly in human studies, the findings so far are promising. The ability of PQQ to protect mitochondria, support motor function, preserve dopaminergic neurons, and reduce harmful protein aggregates all point to its potential as a therapeutic option for Parkinson's disease.


However, it's important to note that most of the research to date has been conducted in animal models or cell cultures. More studies are needed to determine if these benefits translate to humans and to establish the most effective dosages and methods of administration.


Should You Consider PQQ alongside MacuDopa?


If you or a loved one is living with Parkinson's disease, the idea of taking a supplement like PQQ might be appealing. It's crucial to consult with a healthcare provider before starting any new supplement, especially since Parkinson's disease and its treatments are complex. Your health professional can help you weigh the potential benefits and risks, considering your specific health needs and treatment plan.


In the meantime, keep an eye on ongoing research, as scientists continue to explore the full potential of PQQ and other compounds in the fight against Parkinson's disease.

 
 

'Living well naturally with Parkinson's until there is a cure.'

  • MacuDopa Facebook page
  • MacuDopa Twitter X Account

Email us: hello@macudopa.com

Call or text us:  +44 (0) 7931 293 934 

Monday to Friday 9am to 5pm UK time

 
DISCLAIMER
​This website is for customers in the United States of America and worldwide ONLY. If you are a UK citizen looking to buy Macudopa please visit our UK site.
All the information included on this website is for information purposes only. It is not intended to treat or diagnose any medical condition, nor is it intended as a substitute for medical advice. We do not suggest using Mucuna pruriens to treat Parkinson's unless prescribed by your medical professional. If you are concerned about any symptoms please visit your doctor for investigation and diagnosis. For medical diagnosis and treatment please consult your specialist or doctor. The statements regarding Mucuna have not been evaluated by the Food and Drug Administration. These product is not intended to diagnose, treat, cure, or prevent any disease.
© 2025 CogniBrain LTD. All rights reserved.
The content provided in connection with MacuDopa, including but not limited to text, product descriptions, research summaries, FAQs, and proprietary information regarding our Mucuna-based formulation, is protected under copyright law. Unauthorized use, reproduction, or distribution of any part of this content is prohibited without prior written permission from CogniBrain LTD. MacuDopa and related intellectual property are the sole property of CogniBrain LTD, and any infringement will be pursued to the fullest extent permitted by law.
bottom of page